A pilot study of Bifidobacterium breve in neonates undergoing surgery for congenital heart disease

Journal of Intensive Care

Volumn 2, Issue 1, 2014, Pages

  Umenai, Takako ^a,b   Shime, Nobuaki ^b,c   Asahara, Takashi ^d   Nomoto, Koji ^d   Itoi, Toshiyuki ^b  

^a Shimada Hospital   (Japan)

^b KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^c NATIONAL HOSPITAL ORGANIZATION KYOTO MEDICAL CENTER   (Japan)

^d YAKULT CENTRAL INSTITUTE FOR MICROBIOLOGICAL RESEARCH   (Japan)

Author keywords

Congenital heart surgery; Intestinal microbiota; Neonates; Probiotics

Indexed keywords

ADULT; ARTICLE; ARTIFICIAL VENTILATION; BACTERIAL COUNT; BIFIDOBACTERIUM BREVE; CONGENITAL HEART DISEASE; FECES MICROFLORA; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INTENSIVE CARE UNIT; INTESTINE FLORA; MAJOR CLINICAL STUDY; MALE; NONHUMAN; OUTCOME ASSESSMENT; POSTOPERATIVE CARE; PRIORITY JOURNAL;

EID: 84979195122     PISSN: None     EISSN: 20520492     Source Type: Journal    
DOI: 10.1186/2052-0492-2-36     Document Type: Article

References (22)

1. Bakshi KD, Vaidyanathan B, Sundaram KR, Roth SJ, Shivaprakasha K, Rao SG, Nair SG, Chengode S. Determinants of early outcome after neonatal cardiac surgery in a developing country. J Thorac Cardiovasc Surg 2007, 134:765-771. 10.1016/j.jtcvs.2007.04.042, 17723831.
2. Baker GM, O'Brien SM, Welke KF, Jacobs ML, Jacobs JP, Benjamin DK, Peterson ED, Jaggers J, Li JS. Major infection after pediatric cardiac surgery: a risk estimation model. Ann Thorac Surg 2010, 89:843-850. 10.1016/j.athoracsur.2009.11.048, 3319976, 20172141.
3. Morgan CJ, Zappitelli M, Robertson CM, Alton GY, Sauve RS, Joffe AR, Ross DB, Rebeyka IM. Risk factors for and outcomes of acute kidney injury in neonates undergoing complex cardiac surgery. J Pediatr 2013, 162:120-127. 10.1016/j.jpeds.2012.06.054, 22878115.
4. Wheat JC. Nutritional management of children with congenital heart disease. http://www.escholarship.org/uc/item/6jh767ps.
5. Pathan N, Burmester M, Adamovic T, Berk M, Ng KW, Betts H, Macrae D, Waddell S, Paul-Clark M, Nuamah R, Mein C, Levin M, Montana G, Mitchell JA. Intestinal injury and endotoxemia in children undergoing surgery for congenital heart disease. Am J Respir Crit Care Med 2011, 184:1261-1269. 10.1164/rccm.201104-0715OC, 21868501.
6. Papoff P, Ceccarelli G, d'Ettorre G, Cerasaro C, Caresta E, Midulla F, Moretti C. Gut microbial translocation in critically ill children and effects of supplementation with pre- and pro biotics. Int J Microbiol 2012, doi.2012:151393.
7. Joint FAO/WHO Working Group Guidelines for the evaluation of probiotics in food. London Ontario, Canada April 30 and May 1, 2002. ftp://ftp.fao.org/es/esn/food/wgreport2.pdf, Joint FAO/WHO Working Group.
8. Barraud D, Blard C, Hein F, Marcon O, Cravoisy A, Nace L, Alla F, Bollaert PE, Gibot S. Probiotics in the critically ill patient: a double blind, randomized, placebo-controlled trial. Intensive Care Med 2010, 36:1540-1547. 10.1007/s00134-010-1927-0, 20502866.
9. Shimizu K, Ogura H, Goto M, Asahara T, Nomoto K, Morotomi M, Matsushima A, Tasaki O, Fujita K, Hosotsubo H, Kuwagata Y, Tanaka H, Shimazu T, Sugimoto H. Synbiotics decrease the incidence of septic complications in patients with severe SIRS: a preliminary report. Dig Dis Sci 2009, 54:1071-1078. 10.1007/s10620-008-0460-2, 18726154.
10. Ohigashi S, Hoshino Y, Ohde S, Onodera H. Functional outcome, quality of life, and efficacy of probiotics in postoperative patients with colorectal cancer. Surg Today 2011, 41:1200-1206. 10.1007/s00595-010-4450-6, 21874415.
11. Usami M, Miyoshi M, Kanbara Y, Aoyama M, Sakaki H, Shuno K, Hirata K, Takahashi M, Ueno K, Tabata S, Asahara T, Nomoto K. Effects of perioperative synbiotic treatment on infectious complications, intestinal integrity, and fecal flora and organic acids in hepatic surgery with or without cirrhosis. JPEN J Parenter Enteral Nutr 2011, 35:317-328. 10.1177/0148607110379813, 21527594.
12. Asahara T, Nomoto K, Shimizu K, Watanuki M, Tanaka R. Increased resistance of mice to Salmonella enterica serovar Typhimurium infection by synbiotic administration of Bifidobacteria and transgalactosylated oligosaccharides. J Appl Microbiol 2001, 91:985-996. 10.1046/j.1365-2672.2001.01461.x, 11851805.
13. Yasui H, Ohwaki M. Enhancement of immune response in Peyer's patch cells cultured with Bifidobacterium breve. J Dairy Sci 1991, 74:1187-1195. 10.3168/jds.S0022-0302(91)78272-6, 1860970.
14. Ellis CL, Rutledge JC, Underwood MA. Intestinal microbiota and blue baby syndrome: probiotic therapy for term neonates with cyanotic congenital heart disease. Gut Microbes 2010, 1:359-366. 10.4161/gmic.1.6.14077, 3056099, 21468216.
15. Kitajima H, Sumida Y, Tanaka R, Yuki N, Takayama H, Fujimura M. Early administration of Bifidobacterium breve to preterm infants: randomized controlled trial. Arch Dis Child Fetal Neonatal Ed 1997, 76:F101-F107. 10.1136/fn.76.2.F101, 1720633, 9135288.
16. Wada M, Nagata S, Saito M, Shimizu T, Yamashiro Y, Matsuki T, Asahara T, Nomoto K. Effects of the enteral administration of Bifidobacterium breve on patients undergoing chemotherapy for pediatric malignancies. Supp Care Cancer 2010, 18:751-759.
17. Matsuda F, Chowdhury MI, Saha A, Asahara T, Nomoto K, Tarique AA, Ahmed T, Nishibuchi M, Cravioto A, Qadri F. Evaluation of a probiotics, Bifidobacterium breve BBG-01, for enhancement of immunogenicity of an oral inactivated cholera vaccine and safety: a randomized, double-blind, placebo-controlled trial in Bangladeshi children under 5 years of age. Vaccine 2011, 29:1855-1858. 10.1016/j.vaccine.2010.12.133, 21236234.
18. Matsuda K, Tsuji H, Asahara T, Matsumoto K, Takada T, Nomoto K. Establishment of an analytical system for the human fecal microbiota, based on reverse transcription-quantitative PCR targeting of multicopy rRNA molecules. Appl Environ Microbiol 2009, 75:1961-1969. 10.1128/AEM.01843-08, 2663197, 19201979.
19. Fujimoto J, Tanigawa K, Kudo Y, Makino H, Watanabe K. Identification and quantification of viable Bifidobacterium breve strain Yakult in human faeces by using strain-specific primers and propidium monoazide. J Appl Microbiol 2011, 110:209-217. 10.1111/j.1365-2672.2010.04873.x, 21029276.
20. Hijova E, Chmelarova A. Short chain fatty acids and colonic health. Bratisl Lek Listy 2007, 108:354-358.
21. Shin R, Suzuki M, Morishita Y. Influence of intestinal anaerobes and organic acids on the growth of enterohaemorrhagic Escherichia coli O157:H7. J Med Microbiol 2002, 51:201-206.
22. Tanaka K, Yano M, Motoori M, Kishi K, Miyashiro I, Ohue M, Ohigashi H, Asahara T, Nomoto K, Ishikawa O. Impact of perioperative administration of synbiotics in patients with esophageal cancer undergoing esophagectomy: a prospective randomized controlled trial. Surgery 2012, 152:832-842. 10.1016/j.surg.2012.02.021, 22503510.